ABIOMED Shares Outstanding 2006-2019 | ABMD

ABIOMED shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • ABIOMED shares outstanding for the quarter ending March 31, 2019 were 0.046B, a 0.66% increase year-over-year.
  • ABIOMED 2019 shares outstanding were 0.046B, a 0.66% increase from 2018.
  • ABIOMED 2018 shares outstanding were 0.046B, a 2.67% increase from 2017.
  • ABIOMED 2017 shares outstanding were 0.045B, a 0.53% decline from 2016.
ABIOMED Annual Shares Outstanding
(Millions of Shares)
2019 46
2018 46
2017 45
2016 45
2015 43
2014 42
2013 41
2012 40
2011 37
2010 37
2009 35
2008 32
2007 27
2006 26
2005 22
ABIOMED Quarterly Shares Outstanding
(Millions of Shares)
Q4 2019 46
Q3 2018 46
Q2 2018 46
Q1 2018 46
Q4 2018 46
Q3 2017 46
Q2 2017 46
Q1 2017 46
Q4 2017 45
Q3 2016 45
Q2 2016 45
Q1 2016 45
Q4 2016 45
Q3 2015 45
Q2 2015 45
Q1 2015 44
Q4 2015 43
Q3 2014 43
Q2 2014 42
Q1 2014 40
Q4 2014 42
Q3 2013 42
Q2 2013 41
Q1 2013 39
Q4 2013 41
Q3 2012 41
Q2 2012 42
Q1 2012 42
Q4 2012 40
Q3 2011 40
Q2 2011 39
Q1 2011 38
Q4 2011 37
Q3 2010 37
Q2 2010 37
Q1 2010 37
Q4 2010 37
Q3 2009 37
Q2 2009 37
Q1 2009 37
Q4 2009 35
Q3 2008 36
Q2 2008 34
Q1 2008 33
Q4 2008 32
Q3 2007 32
Q2 2007 32
Q1 2007 32
Q4 2007 27
Q3 2006 27
Q2 2006 27
Q1 2006 26
Q4 2006 26
Q3 2005 26
Q2 2005 26
Q1 2005 24
Q4 2005 22
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $11.491B $0.769B
Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company'sproducts are used in the cardiac catheterization lab, or cath lab, by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $114.479B 25.04
Intuitive Surgical (ISRG) United States $59.521B 54.85
Edwards Lifesciences (EW) United States $39.100B 39.07
IDEXX Laboratories (IDXX) United States $24.408B 64.03
Fresenius Medical Care AG KGaA (FMS) Germany $24.241B 15.93
Teleflex (TFX) United States $15.301B 33.15
Olympus (OCPNY) Japan $15.078B 112.82
SONOVA HOLDING (SONVY) Switzerland $14.501B 0.00
Sysmex ADR (SSMXY) Japan $14.145B 38.13
DexCom (DXCM) United States $13.644B 267.59
Hologic (HOLX) United States $12.620B 20.29
STERIS (STE) Ireland $12.544B 30.34
Varian Medical Systems (VAR) United States $12.269B 31.30
Masimo (MASI) United States $8.109B 49.69
Penumbra (PEN) United States $5.895B 249.54
SARTORIUS AG (SARTF) Germany $5.850B 53.60
Elekta AB (EKTAY) Sweden $5.153B 38.83
Integra LifeSciences Holdings (IART) United States $4.555B 21.40
Globus Medical (GMED) United States $4.118B 25.68
Tandem Diabetes Care (TNDM) United States $3.627B 0.00
LivaNova (LIVN) United Kingdom $3.564B 23.23
Wright Medical Group (WMGI) Netherlands $3.321B 658.25
Cantel Medical (CMD) United States $3.301B 33.49
Glaukos (GKOS) United States $2.752B 0.00
Integer Holdings (ITGR) United States $2.651B 19.54
Nihon Kohden (NHNKY) Japan $2.366B 23.80
AVANOS MEDICAL, INC (AVNS) United States $1.989B 31.47
Nevro (NVRO) United States $1.941B 0.00
Inogen (INGN) United States $1.360B 30.11
OPKO Health (OPK) United States $1.293B 0.00
Silk Road Medical (SILK) United States $1.252B 0.00
Veracyte (VCYT) United States $1.187B 0.00
CryoLife (CRY) United States $1.093B 108.41
Tactile Systems Technology (TCMD) United States $1.043B 153.92
Accelerate Diagnostics (AXDX) United States $1.041B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.966B 27.98
Mesa Laboratories (MLAB) United States $0.914B 42.99
Pacific Biosciences Of California (PACB) United States $0.901B 0.00
Luminex (LMNX) United States $0.894B 116.94
ViewRay (VRAY) United States $0.887B 0.00
Natus Medical (BABY) United States $0.887B 20.53
AngioDynamics (ANGO) United States $0.796B 26.10
AxoGen (AXGN) United States $0.764B 0.00
Fluidigm (FLDM) United States $0.752B 0.00
Quotient (QTNT) Switzerland $0.693B 0.00
Intersect ENT (XENT) United States $0.640B 0.00
OrthoPediatrics (KIDS) United States $0.559B 0.00
Corindus Vascular Robotics (CVRS) United States $0.544B 0.00
Si-Bone (SIBN) United States $0.488B 0.00
GenMark Diagnostics (GNMK) United States $0.356B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.351B 18.81
Accuray (ARAY) United States $0.317B 0.00
RTI Surgical (RTIX) United States $0.312B 38.36
TransEnterix (TRXC) United States $0.306B 0.00
Semler Scientific (SMLR) United States $0.291B 57.78
SeaSpine Holdings (SPNE) United States $0.239B 0.00
Neuronetics (STIM) United States $0.231B 0.00
ConforMIS (CFMS) United States $0.231B 0.00
IRadimed (IRMD) United States $0.202B 38.53
Alphatec Holdings (ATEC) United States $0.201B 0.00
CRH Medical (CRHM) Canada $0.199B 69.00
Sientra (SIEN) United States $0.180B 0.00
Stereotaxis (STXS) United States $0.172B 0.00
Second Sight Medical Products (EYES) United States $0.101B 0.00
Ekso Bionics Holdings (EKSO) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.088B 0.00
Vermillion (VRML) United States $0.083B 0.00
EDAP TMS S.A (EDAP) France $0.078B 0.00
T2 Biosystems (TTOO) United States $0.076B 0.00
Covalon Technologies (CVALF) Canada $0.070B 0.00
Apollo Endosurgery (APEN) United States $0.069B 0.00
Spectral Diagnostics (EDTXF) Canada $0.066B 0.00
Helius Medical Technologies (HSDT) United States $0.055B 0.00